Reduction in SIV replication in rhesus macaques infused with autologous lymphocytes engineered with antiviral genes

[1]  G. Pantaleo.  How immune-based interventions can change HIV therapy , 1997, Nature Medicine.

[2]  R. Morgan,et al.  Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. , 1997, Blood.

[3]  Bruce L. Levine,et al.  Antiviral Effect and Ex Vivo CD4+ T Cell Proliferation in HIV-Positive Patients as a Result of CD28 Costimulation , 1996, Science.

[4]  R. Morgan,et al.  Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. , 1996, Human gene therapy.

[5]  N. Haigwood,et al.  Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. , 1996, Immunology letters.

[6]  G. Nabel,et al.  Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Donahue,et al.  Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor. , 1996, Blood.

[8]  R. Morgan,et al.  High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. W. Wong,et al.  Suppression of simian immunodeficiency virus replication by human immunodeficiency virus type 1 trans-dominant negative rev mutants , 1995, Journal of virology.

[10]  R. Morgan,et al.  Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes , 1995, Journal of virology.

[11]  J. Clements,et al.  Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus , 1995, Journal of virology.

[12]  J. Clements,et al.  Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro , 1994, Journal of virology.

[13]  N. Pedersen,et al.  A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge , 1994, Journal of virology.

[14]  N. Haigwood,et al.  Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.

[15]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[16]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[17]  D. Baltimore,et al.  HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus , 1989, Cell.

[18]  D. Baltimore.  Intracellular immunization , 1988, Nature.

[19]  M. Siekevitz,et al.  Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-I. , 1987, Science.

[20]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[21]  M. Endres,et al.  The Simian Retroviruses SIV and SRV , 1994 .

[22]  T. Kindt,et al.  Animal models for acquired immunodeficiency syndrome. , 1992, Advances in immunology.